ASGPR1 (8D7) Antibody sc-52623 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemASGPR1 (8D7) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-52623
Antibody TypePrimary Antibodies
NCBI Gene AliasesHL-1, ASGPR, ASGR, Asgr-1, ASGPR1, RATRHL1, Asgr, CLEC4H1, RHL1
Quantity200 µg/ml
Clone8D7
Reactivitymouse, rat, human
ApplicationsWB, IP, IF, FCM
Hostmouse
ClonalityMonoclonal
Conjugate/TagUnconjugated
FormatPurified
NCBI Full Gene Nameasialoglycoprotein receptor 1
IsotypeIgG1
TargetASGPR1

Questions and Answers

Can this antibody be used for isolating hepatocytes in microfluidic devices?

Yes, the ASGPR1 (8D7) antibody has been shown to be effective in capturing hepatocytes when used in microfluidic devices. In a study, it was utilized alongside other antibodies for the co-patterning and isolation of hepatocytes and endothelial cells, demonstrating its utility in complex cellular geometries in vitro ().

Is the ASGPR1 antibody suitable for Western blot applications?

The ASGPR1 antibody has been successfully used in Western blotting to identify hepatocyte-specific markers. In one study, it was employed at a dilution of 1:1000 to detect ASGPR1 in protein samples, indicating its effectiveness in this application ().

What species does this antibody react with?

The ASGPR1 antibody is reactive with multiple species, including human, mouse, and rat. This broad reactivity makes it a versatile tool for studies involving these organisms.

Has this antibody been cited in any recent research?

Yes, the ASGPR1 antibody has been cited in at least 15 scientific articles, indicating its relevance and application in various research contexts, including studies on hepatocyte differentiation and extracellular vesicle characterization (, ).

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Exosomes derived from impaired liver aggravate alveolar bone loss via shuttle of Fasn in type 2 diabetes mellitusBioactive materialsMarch 1, 2024Liu J, Dou G, Zhao W, Hu J, Jiang Z, Wang W, Wang H, Liu S, Jin Y, Zhao Y, et al.Cell Signaling Technology. CD63 (sc-5275), GM130 (sc-55591), GSDMDN-AF594 (sc-393581), ASGPR (sc-166633, sc-52623), CD90-AF488 (sc-53456) and Fasn (sc-48357) were obtained from Santa Cruz Biotechnology. GSDMD (ab219800),

(2) Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like ParticlesSmall (Weinheim an der Bergstrasse, Germany)December 1, 2023Hincapie R, Bhattacharya S, Baksh MM, Sanhueza CA, Echeverri ES, Kim H, Paunovska K, Podilapu AR, Xu M, Dahlman JE, et al.

(3) Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular CarcinomaInternational Journal of Molecular SciencesNovember 7, 2023Bootsakorn Boonkaew, Nantawat Satthawiwat, Nutcha Pinjaroen, Natthaya Chuaypen, Pisit Tangkijvanich(1:2000) (Ab193349, MX-49.129.5, Abcam). To identify hepatocyte-specific markers, ASGPR1 (1:1000) (SC-52623, 8D7, Santa Cruz) was used [41,42]. Following this process, the membrane was stained with horseradish

(4) Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA deliveryNature nanotechnologyAugust 1, 2022Dobrowolski C, Paunovska K, Schrader Echeverri E, Loughrey D, Da Silva Sanchez AJ, Ni H, Hatit MZC, Lokugamage MP, Kuzminich Y, Peck HE, et al.

(5) miR-2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2Liver international : official journal of the International Association for the Study of the LiverJuly 1, 2022Sun B, Ji W, Liu C, Lin X, Chen L, Qian H, Su C.

(6) Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic OrganoidsBiologyMarch 23, 2022Jeong J, Kim TH, Kim M, Jung YK, Kim KS, Shim S, Jang H, Jang WI, Lee SB, Choi D.ab3980, Cambridge, UK), HNF4α (Santa Cruz Biotechnology, sc-8987), ASGR1 (Santa Cruz Biotechnology, sc-52623), CYP1A2 (Santa Cruz Biotechnology, sc-53241), and β-actin (Santa Cruz Biotechnology, sc-47778) were

(7) Construction of a mouse model that can be used for tissue-specific EV screening and tracing in vivoFrontiers in cell and developmental biologyJanuary 1, 2022Li W, Wang J, Yin X, Shi H, Sun B, Ji M, Song H, Liu J, Dou Y, Xu C, et al.primary antibody at dilutions recommended by the suppliers was anti-ASGRP1 (Santa Cruz Biotechnology, sc-52623), anti-CD63 (Santa Cruz Biotechnology, sc-5275), anti-CD9 (Santa Cruz Biotechnology, sc-13118), anti-villin

(8) Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture modelsNature communicationsMay 17, 2021Lombardo JA, Aliaghaei M, Nguyen QH, Kessenbrock K, Haun JB.

(9) 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular CarcinomaOncoTargets and therapyJanuary 1, 2021Hu CL, Zhang YJ, Zhang XF, Fei X, Zhang H, Li CG, Sun B.slides prepared from blood samples were incubated with the primary antibodies (mouse anti-ASGPR antibody sc52623, Santa Cruz; or rabbit anti-CPS1 antibody ab128942, Abcam then stained with the Cy3-conjugated goat

(10) Comparative study between lactose-silk fibroin conjugates and extracellular matrices as a substrate for the culture of human induced pluripotent stem cell-derived hepatocytesBio-medical materials and engineeringJanuary 1, 2020Gotoh Y, Niimi S, Tamura K, Akahira R, Inamura M.

(11) High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinomaScientific reportsAugust 1, 2018D'Avola D, Villacorta-Martin C, Martins-Filho SN, Craig A, Labgaa I, von Felden J, Kimaada A, Bonaccorso A, Tabrizian P, Hartmann BM, et al.

(12) Human Urinary Epithelial Cells as a Source of Engraftable Hepatocyte-Like Cells Using Stem Cell TechnologyCell transplantationDecember 13, 2016Sauer V, Tchaikovskaya T, Wang X, Li Y, Zhang W, Tar K, Polgar Z, Ding J, Guha C, Fox IJ, et al.

(13) One step antibody-mediated isolation and patterning of multiple cell types in microfluidic devicesBiomicrofluidicsMarch 1, 2016Bavli D, Ezra E, Kitsberg D, Vosk-Artzi M, Murthy SK, Nahmias Y.antibodies under flow Biotin-conjugated mouse anti-hCD24 (13-0247-80, eBioscience) and mouse anti-ASGPR1 (SC52623, Santa Cruz Biotechnology) were used to capture hepatocytes. Biotin-conjugated mouse anti-hCD202b/Tie2/Tek

(14) Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity TestingToxicological sciences : an official journal of the Society of ToxicologySeptember 1, 2015Lu J, Einhorn S, Venkatarangan L, Miller M, Mann DA, Watkins PB, LeCluyse E.

(15) A new model to produce infectious hepatitis C virus without the replication requirementPLoS pathogensApril 1, 2011Triyatni M, Berger EA, Saunier B.

Be the First to Write a Review!

ASGPR1 (8D7) Antibody

ASGPR1 (8D7) Antibody from Santa Cruz Biotechnology, Inc.

Description

Questions and Answers

Santa Cruz Biotechnology, Inc.

Citations (15)

Reviews

ASGPR1 (8D7) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map